ACTIVE

DBMed

Export PDF

Financial year 2025 · closed on 30/06/2025

Net result

100,5 k €

+6.6% YoY

Gross margin

166,8 k €

+0.8% YoY

Equity

497,9 k €

+12.7% YoY

What does DBMed do?

DBMed is a Private limited company incorporated in 2011. Its registered office is in Uccle.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0832.797.359

Incorporation

14/01/2011

Legal form

Private limited company

Registered office

Avenue Winston Churchill 192A
1180 Uccle · BruxellesSee on map

Latest accounts

30/06/2025

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 14 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012
Income statement
Gross margin	166,8 k €	+0.8%	165,4 k €	-33.4%	248,6 k €	+85.4%	134,1 k €	+8.4%	123,7 k €	+285%	32,1 k €	-53.7%	69,3 k €	-10.7%	77,6 k €	-20.6%	97,8 k €	-36.0%	152,8 k €	-3.1%	157,6 k €	+38.7%	113,7 k €	+1.8%	111,7 k €	-57.3%	261,6 k €
EBITDA	166 k €	+1.2%	164,1 k €	-33.6%	247,3 k €	+85.4%	133,4 k €	+16.1%	114,8 k €	+266%	31,4 k €	-54.2%	68,4 k €	-10.8%	76,7 k €	-20.6%	96,5 k €	-36.3%	151,6 k €	-2.7%	155,8 k €	+41.1%	110,5 k €	+1.3%	109 k €	-57.7%	257,8 k €
Operating result	144,6 k €	+4.8%	138,1 k €	-38.4%	224 k €	+97.9%	113,2 k €	+20.3%	94,1 k €	+7634%	1,2 k €	-97.4%	46,2 k €	-13.0%	53,1 k €	-19.4%	65,9 k €	-44.9%	119,6 k €	-2.2%	122,3 k €	+52.7%	80,1 k €	+5.6%	75,9 k €	-67.3%	232,4 k €
Net result	100,5 k €	+6.6%	94,3 k €	-38.6%	153,6 k €	+88.9%	81,3 k €	+18.9%	68,3 k €	+4542%	-1,5 k €	-105%	32 k €	-6.4%	34,2 k €	-19.0%	42,2 k €	-34.5%	64,5 k €	-16.0%	76,8 k €	+39.9%	54,9 k €	+6.1%	51,7 k €	-65.8%	151,1 k €
Balance sheet
Equity	497,9 k €	+12.7%	441,9 k €	+27.1%	347,6 k €	+28.5%	270,5 k €	+42.5%	189,8 k €	-35.1%	292,6 k €	-21.1%	370,9 k €	+9.5%	338,9 k €	-22.8%	438,7 k €	+10.7%	396,5 k €	+19.4%	332 k €	+30.1%	255,2 k €	+18.6%	215,2 k €	+31.6%	163,5 k €
Total assets	578,9 k €	+6.1%	545,7 k €	+1.6%	536,9 k €	+37.3%	390,9 k €	-2.6%	401,3 k €	+7.6%	372,9 k €	-0.4%	374,5 k €	-22.9%	485,7 k €	+6.6%	455,4 k €	+2.4%	444,7 k €	+14.9%	387,1 k €	+11.3%	347,9 k €	+6.3%	327,1 k €	+10.2%	297 k €
Cash	244,3 k €	-5.7%	259 k €	+11762%	2,2 k €	-69.8%	7,2 k €		–		633,2 €	-80.6%	3,3 k €		–		3,6 k €	-90.7%	39,1 k €	+545%	6,1 k €	+195%	2,1 k €		–		3,9 k €
Debts	81 k €	-20.8%	102,3 k €	-46.0%	189,2 k €	+57.7%	120 k €	-43.3%	211,5 k €	+163%	80,3 k €	+2149%	3,6 k €	-97.6%	146,8 k €	+779%	16,7 k €	-65.4%	48,2 k €	-12.5%	55,1 k €	-39.3%	90,7 k €	-17.2%	109,5 k €	-16.6%	131,4 k €

Estimate

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€

See the valuation

Governance

Board of directors

Seen on filing of 30/06/2025 · 1 active · 5 ended

Active mandates

Dorothee Berben

Mandate

Active

Ended mandates

Dorothée Berben

Director · since 18 mars 2020

Ended

Dorothee Berben

Director

Ended

Dorothee Berben

Manager

Ended

Dorothee Marie Berben

Director · until 18 mars 2030

Ended

At this address

Other companies at this address

Company	CBE no.
Immed Benelux● Active	0466.908.609
SCINTIMAG● Active	0875.004.633

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Micro model	Micro model	Micro model	Micro model	Micro model	Micro model
Start of the financial year	01/07/2024	01/07/2023	01/07/2022	01/07/2021	01/07/2020	01/07/2019
Closing of the financial year	30/06/2025	30/06/2024	30/06/2023	30/06/2022	30/06/2021	30/06/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	28/02/2026	31/01/2025	31/01/2024	18/01/2023	14/01/2022	02/02/2021
General meeting	19/12/2025	08/01/2025	31/12/2023	16/12/2022	17/12/2021	31/12/2020
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

14 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Micro model	30/06/2025	19/12/2025	28/02/2026	Dutch	PDF
Micro model	30/06/2024	08/01/2025	31/01/2025	Dutch	PDF
Micro model	30/06/2023	31/12/2023	31/01/2024	Dutch	PDF
Micro model	30/06/2022	16/12/2022	18/01/2023	Dutch	PDF
Micro model	30/06/2021	17/12/2021	14/01/2022	Dutch	PDF
Micro model	30/06/2020	31/12/2020	02/02/2021	Dutch	PDF
Micro model	30/06/2019	30/12/2019	30/01/2020	Dutch	PDF
Micro model	30/06/2018	31/12/2018	31/01/2019	Dutch	PDF
Micro model	30/06/2017	29/12/2017	26/01/2018	Dutch	PDF
Abridged model	30/06/2016	16/12/2016	04/01/2017	Dutch	PDF
Abridged model	30/06/2015	18/12/2015	12/01/2016	Dutch	PDF
Abridged model	30/06/2014	19/12/2014	20/01/2015	Dutch	PDF
Abridged model	30/06/2013	20/12/2013	07/02/2014	Dutch	PDF
Abridged model	30/06/2012	20/12/2012	25/01/2013	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 30/06/2025 · 1 active · 5 ended

Active mandates

Dorothee Berben

Mandate

Active

Ended mandates

Dorothée Berben

Director · since 18 mars 2020

Ended

Dorothee Berben

Director

Ended

Dorothee Berben

Manager

Ended

Dorothee Marie Berben

Director · until 18 mars 2030

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates27/03/2020
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - BENAMING - DIVERSEN - ONTSLAGEN - BENOEMINGEN
PDF
Capital / shares10/07/2018
KAPITAAL - AANDELEN
PDF
Mandates30/06/2014
KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Capital / shares08/12/2011
KAPITAAL - AANDELEN - DIVERSEN
PDF
Other11/03/2011
DIVERSEN
PDF
Other26/01/2011
RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025100,5 k €↑
2024
Annual accounts 202494,3 k €↓
2023
Annual accounts 2023153,6 k €↑
2022
Annual accounts 202281,3 k €↑
2021
Annual accounts 202168,3 k €↑
2020
Annual accounts 2020-1,5 k €↓
2019
Annual accounts 201932 k €↓
2018
Annual accounts 201834,2 k €↓
2017
Annual accounts 201742,2 k €↓
2016
Annual accounts 201664,5 k €↓
2015
Annual accounts 201576,8 k €↑
2014
Annual accounts 201454,9 k €↑
2013
Annual accounts 201351,7 k €↓
2012
Annual accounts 2012151,1 k €
14/01/2011
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

DBMed

Overview

What does DBMed do?

Trend over 14 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline